USRM - U.S. Stem Cell, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0275
+0.0005 (+1.85%)
At close: 3:46PM EDT
Stock chart is not supported by your current browser
Previous Close0.0270
Open0.0275
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0265 - 0.0275
52 Week Range0.0160 - 0.0880
Volume334,091
Avg. Volume2,008,952
Market Cap10.038M
Beta12.38
PE Ratio (TTM)N/A
EPS (TTM)-0.0030
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.40
Trade prices are not sourced from all markets
  • Stem Cells Shows Promise For Repairing Torn Meniscus
    PR Newswire10 days ago

    Stem Cells Shows Promise For Repairing Torn Meniscus

    Results are published in the scientific publication the Journal of Medical Cases, and is authored by USRM Chief Science Officer Dr. Kristin Comella and colleagues Dr. Scott Greenberg of the Magaziner Center for Wellness, and Dr. Laura Ross of Ross Orthopedic.

  • 'Renewing Our Heroes' to Provide USRM Stem Cell Protocol to First Responders
    PR Newswirelast month

    'Renewing Our Heroes' to Provide USRM Stem Cell Protocol to First Responders

    SUNRISE, Fla., June 5, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Renewing Our Heroes  -- a charitable health initiative established to provide first responders and other civil service personnel with access to alternative medical care they would otherwise be unable to obtain -- will now offer USRM stem cell procedures and protocols to its recipients following injuries and conditions that occur in the line of duty. Established by Joseph Radich, Founder and Clinical Director of  RenewU Medical and son of an actively serving New York City firefighter, Renewing Our Heroes was created as a charitable health initiative to help individuals who voluntarily and without hesitation put their bodies, minds, families and lives on the line every day.

  • USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference
    PR Newswire2 months ago

    USRM Chief Science Officer to Present at Fifth Annual Cell Surgical World Conference

    SUNRISE, Fla., June 1, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will be presenting at the Fifth Annual Cell Surgical World Conference in Beverly Hills this Saturday, June 2. Dr. Comella is, to the Company's best knowledge, one of the most published scientists in the clinical use of fat derived autologous stem cells.  Her work in the application of autologous (a patient's own) stem cell therapy is unparalleled, and includes autoimmune, neurodegenerative, orthopedic and degenerative conditions.  To date, the company has worked with more than 10,000 patients and trained more than 700+ physicians worldwide.

  • USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with 'Something Significant' Happy Living Podcast
    PR Newswire2 months ago

    USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with 'Something Significant' Happy Living Podcast

    SUNRISE, Fla., May 17, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, is featured in the 'Something Significant' Happy Living podcast with former NFL player Matt Gersper, where she discusses the inception of her work more than 19 years ago and how she and USRM's development of novel, therapeutic adipose (fat derived) stem cell treatments, is changing lives. The interview is available for complementary playback here.

  • World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference
    PR Newswire2 months ago

    World Bodybuilding Expert Interviews USRM Chief Science Officer At Paleo F(X) Conference

    SUNRISE, Fla., May 15, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the release of USRM Chief Science Officer Dr. Kristin Comella's interview with Ben Pakulski -- a world bodybuilding expert who last year received autologous stem cell therapy that successfully treated torn muscles.  Listen to the interview here, or at https://www.benpakulski.com/comella. Dr. Comella, a world renowned expert in the development and clinical application of autologous stem cell products and therapies, is one voice in a growing movement recognizing the power of regenerative medicine and, in particular, autologous stem cell therapy.

  • Autologous Stem Cell Therapy May Hold Key to Regeneration
    PR Newswire2 months ago

    Autologous Stem Cell Therapy May Hold Key to Regeneration

    SUNRISE, Fla., May 14, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the release of USRM Chief Science Officer Dr. Kristin Comella's Stem Cell 101 Webinar from last Friday, now available for complimentary playback via live link, http://www.brainshark.com/Stemlogix/vu?pi=zGWzp5LSBz5OLvz0. Dr. Comella, a world renowned expert in the development and clinical application of autologous stem cell products and therapies, is one voice in a growing movement recognizing the power of regenerative medicine and, in particular, autologous stem cell therapy.

  • USRM Chief Science Officer, Dr. Kristin Comella, Featured on Health Boot Camps' Webinar
    PR Newswire2 months ago

    USRM Chief Science Officer, Dr. Kristin Comella, Featured on Health Boot Camps' Webinar

    SUNRISE, Fla., May 10, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions,  today announced its Chief Science Officer, Dr. Kristin Comella, is a featured guest on Health Boot Camps' "The Fountain of Health Has Been Found: An Interview with Dr. Kristin Comella," now available on podcast here. Dr. Comella is extensively published in the scientific literature in the practical application of autologous stem cell therapy.  Last month, she and her team were the first in the world to publish in-human results in scientific literature of adipose stem cell therapy significantly reducing psoriasis -- a condition that affects 7 million plus Americans annually.

  • U.S. Department of Justice Files Lawsuit at Request of FDA to Stop U.S. Stem Cell Clinic from Performing Autologous Stem Cell Procedure
    PR Newswire2 months ago

    U.S. Department of Justice Files Lawsuit at Request of FDA to Stop U.S. Stem Cell Clinic from Performing Autologous Stem Cell Procedure

    USRM Will Vigorously Defend Medical Freedom of Americans SUNRISE, Fla. , May 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a world leader in the development of proprietary, physician-based ...

  • U.S. Stem Cell Reports First Quarter Results
    PR Newswire2 months ago

    U.S. Stem Cell Reports First Quarter Results

    SUNRISE, Fla., May 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced first quarter results for 2018. For two consecutive years, USRM has sustained substantial revenue growth, which may be attributable to an increased awareness of stem cell therapy, as Americans seek alternatives to pain management and opioids.

  • USRM Chief Science Officer to Host Webinar on Autologous Stem Cell Therapy
    PR Newswire2 months ago

    USRM Chief Science Officer to Host Webinar on Autologous Stem Cell Therapy

    MIAMI, May 8, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will host a live webinar designed to inform the public about the benefits and science behind autologous stem cell therapy. "Stem Cells 101: A Patient's Guide to Autologous Stem Cell Therapy" will livestream Friday, May 11th, at twelve noon EST.  Participants who livestream the webinar may also post questions to Dr. Comella, who will answer as many livestream questions as she can during the session. "Stem Cells 101: A Patient's Guide to Autologous Stem Cell Therapy"  will also be recorded and posted following the livestream on U.S. Stem Cell's website and in social media.

  • USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki
    PR Newswire3 months ago

    USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki

    MIAMI, May 3, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announced its Chief Science Officer, Dr. Kristin Comella, appeared live today as a featured guest for the Biohacker Summit blog -- a component of the Biohacker Center in Helsinki, Finland.  Free online viewing of the live interview on stem cells is available in its entirety here. Dr. Comella, who has more than 20+ years' experience and is a world renowned expert in the development and clinical practice of stem cell products and therapies, is extensively published in the scientific literature in the practical application of autologous (a patient's own) stem cell therapy.  Last month, Dr. Comella and her team were the first in the world to publish in the scientific literature in-human results of adipose stem cell therapy significantly reducing psoriasis — a condition that affects more than 7 million Americans annually.

  • Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
    PR Newswire3 months ago

    Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales

    SUNRISE, Fla., April 24, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced sales figures for 2016 and 2017 for both its AdipoCell TM proprietary stem cell kit and the stem cell banking businesses -- both of which demonstrate steady growth.

  • USRM Announces 2017 Financial Results
    PR Newswire3 months ago

    USRM Announces 2017 Financial Results

    SUNRISE, Fla., April 16, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today filed a Form 10-K reporting year-end numbers for 2017, which reflect continued growth and increased cash flow from operations. Revenue for 2017 increased 79% to $5.5m -- up $2.4m from $3.1m in 2016.  Revenue also increased 53% in the fourth quarter of 2017 to $964k from $508k in the same quarter in 2016.  Net gross profit in 2017 increased 72% to $2.1m from $1.5m in the previous year.  For the fourth quarter 2017, net gross profit was also up while overall debt decreased.

  • PR Newswire3 months ago

    Newest Clinic Opens Today at The Villages in Central Florida

    SUNRISE, Fla., April 9, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the opening its first USRM clinic in North Central Florida. The U.S. Stem Cell Clinic of The Villages will offer alternatives to chronic pain management using USRM's proprietary AdipocellTM product in a minimally invasive procedure utilizing a patient's own (autologous) stem cells.  Medical director for the clinic will be Dr. Rosemary Daly, an interventional spine/pain management physician who is board certified in Anesthesiology and Pain Medicine.  Dr. Daly, who graduated from the New York College of Osteopathic Medicine, is also medical director for the Regenerative Wellness Clinic (RWC) in West Palm Beach, which is also in the USRM network of stem cell treatment centers.

  • USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells
    PR Newswire4 months ago

    USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells

    SUNRISE, Fla., March 21, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has published in the scientific literature that it has successfully demonstrated a 99 percent reduction in-human of the severity of psoriasis using a patient's autologous stem cells. To the best of USRM management's knowledge, this is the first result in the world published using stromal vascular fraction (SVF) and autologous stem cells in the successful treatment of psoriasis.

  • PR Newswire4 months ago

    USRM Chief Science Officer to Present at Paleo f(x) Ancestral Healing Conference in Austin, Texas

    SUNRISE, Fla., March 20, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, is pleased to announce its Chief Science Officer, Dr. Kristin Comella, has accepted an invitation to present at the 2018 Paleo f(x) Ancestral Healing Conference Friday, April 27, at the Palmer Events Center in Austin, Texas. Dr. Comella will present "Regenerative Medicine: The Future of Medicine is Here," at 4:25 p.m. CST at the Kegenix Paleo On Ramp Stage.  Her presentation will be livestreamed on the USRM facebook page, follow to receive a live notification.

  • ACCESSWIRE4 months ago

    New Research: Key Drivers of Growth for U.S. Stem Cell Inc. and Elite Pharmaceuticals - Factors of Influence, Major Initiatives and Sustained Production

    NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of U.S. Stem Cell Inc. ( OTCQB: USRM ) and Elite Pharmaceuticals Inc. ...

  • USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference
    PR Newswire5 months ago

    USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference

    SUNRISE, Fla., Feb. 28, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announces our participation in this year's fourth annual Academy of Regenerative Practices' Conference, which kicks off tomorrow and continues through March 2 & 3 at the Bonaventure Resort & Spa in Weston, Florida. The Conference, which hosts some of the world's leading regenerative scientists, health and medical professionals -- including USRM's Chief Science Officer & ARP President Dr. Kristin Comella -- will feature more than 29 speakers including Dr. Joseph Mercola, Dr. Josh Axe & Ben Greenfield. The annual event also provides doctors and physicians the opportunity to receive hands-on, accredited, continuing education training in performing stem cell procedures.  Doctors are able to gain the ability to augment their practice with this cutting-edge, regenerative therapy -- a process that is becoming increasingly in demand amongst the patient population in the United States suffering from neurological, autoimmune, orthopedic and degenerative conditions.

  • USRM Posts Live Webinar with World Renowned Biohacker
    PR Newswire5 months ago

    USRM Posts Live Webinar with World Renowned Biohacker

    SUNRISE, Fla., Feb. 20, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has posted a live playback of its Saturday webinar here, "Enhancing Sexual Performance with Stem Cell Therapy" --  an informative Q & A with USRM Chief Science Officer Dr. Kristin Comella and leading biohacker and CEO of health company Kion, Ben Greenfield, who recently had penile stem cell injections to enhance sexual performance. Greenfield, who recently received stromal vascular fraction treatments (SVF) intravenously for overall bioenhancement, as well as penile injections for erectile enhancement, says as a result of the treatments his overall healing function as well as sexual performance has been significantly enhanced.

  • USRM CSO to Host Live Stem Cell Info Webinar with World Renowned Biohacker
    PR Newswire5 months ago

    USRM CSO to Host Live Stem Cell Info Webinar with World Renowned Biohacker

    SUNRISE, Fla., Feb. 14, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will host a live webinar open to the public with Ben Greenfield -- a leading biohacker and fitness expert and CEO of health company Kion-- who recently had penile stem cell injections to enhance sexual performance. "Enhancing Sexual Performance with Stem Cell Therapy," will be a live-streamed discussion and Q & A with Dr. Comella and Greenfield Saturday, Feb. 17, at Noon EST.

  • USRM Successfully Launches Stem Cell Webinar Series
    PR Newswire5 months ago

    USRM Successfully Launches Stem Cell Webinar Series

    SUNRISE, Fla., Feb. 12, 2018 /PRNewswire/ -- Dr. Kristin Comella, Chief Science Officer of U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the successful launch of an open, livestream webinar series designed to inform and educate the public on the benefits and applications of stem cell therapy. "Facts About Stem Cell Therapy," which had its first live broadcast last Friday and includes a question & answer session from more than 100 patients and physicians around the world, continued for nearly two hours while live streamers posted questions to Dr. Comella about the application of autologous stem cells therapy.  Such a strong, positive response demonstrates the growing demand for information about this emerging, holistic, regenerative therapy.

  • USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
    PR Newswire5 months ago

    USRM Seeing Explosive Increase in Demand for Stem Cell Therapy

    SUNRISE, Fla., Feb. 6, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it is experiencing explosive demand for stem cell treatments at its clinics -- a trend that is reflected in the 106% increase in revenues during the 3rd Q and is continuing as a result of rapidly increasing demand from the marketplace. As a result, USRM Chief Science Officer Dr. Kristin Comella, who is featured in the docuseries, "The Healing Miracle: The Truth About Stem Cells," will be hosting a live webinar Friday, Feb. 9, to help answer questions about stem cell therapy and treatments. "Our phones are ringing off the hook," said Dr. Comella.  "Public demand is ramping up quickly, as Americans invest in educating themselves on stem cell therapy and alternatives to opioid protocols for chronic pain.  Moreover, because stem cell therapy is an out-of-pocket expense, improved economic indicators are giving Americans more money in their pockets for discretionary spending, which is increasing opportunity for stem cell treatments," said Dr. Comella.

  • USRM Chief Science Officer Featured in Powerful Stem Cell Docuseries
    PR Newswire6 months ago

    USRM Chief Science Officer Featured in Powerful Stem Cell Docuseries

    SUNRISE, Fla., Jan. 24, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, has been featured in the docuseries, "The Healing Miracle: The Truth About Stem Cells" -- a film that interviews renowned experts in the field of stem cell medicine and explores in-depth the benefits and application of regenerative stem cell therapy. In the documentary, Dr. Comella (who has worked with all kinds of stem cells including, bone, muscle and fat), recounts an emotional experience with a patient who presented with a two-year-old head trauma and was wheelchair bound.   Following her stem cell protocol with Dr. Comella and USRM, she had a life-changing experience.

  • USRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product
    PR Newswire6 months ago

    USRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product

    SUNRISE, Fla., Jan. 15, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has reached a key milestone of 10,000 kit sales of its proprietary Adipocell™ product, a direct result of its relationships with 287 clinics in the United States and 700+ physicians worldwide offering USRM's proprietary stem cell products and services. Adipocell™, which has been developed, marketed and distributed by USRM, enables physicians to separate potent stem cells from a patient's own (autologous) fat cells, which are harvested and reinserted in two-hours total, in a minimally invasive procedure.

  • PR Newswire6 months ago

    USRM Stem Cell Treatment Shows Promise in Enhancing Erectile Function

    SUNRISE, Fla., Jan. 8, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced world-renowned fitness expert Ben Greenfield successfully received its stromal vascular fraction treatment for erectile enhancement.  Details of the procedure and the results are featured in the January issue of Men's Health, on newsstands now. Stromal vascular fraction treatments, or autologous stem cell treatments harvested from the patient's own fat, could provide healthier alternatives to use of pharmaceuticals for erectile enhancement and dysfunction (ED) — a market that is estimated to be more than $4 billion annually and has slowed in growth due to toxic side effects from pharmaceuticals currently on the market, according to a report by Grand View Research published in July 2016.  Greenfield, who is a self-professed 'biohacker,' sought treatment as part of his ongoing exploration of 'biohacking' and penile enhancement.